Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.
Department of Infectious Diseases and The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China.
DNA Cell Biol. 2021 Mar;40(3):513-522. doi: 10.1089/dna.2020.6214. Epub 2021 Jan 8.
N1-methyladenosine (m1A) is a prevalent RNA modification widely affecting RNA structural stability, folding, and interactions with proteins. Recently, there have been increasing reports on the roles of m1A regulators in tumors. However, their mechanisms and clinical relevance remain unclear. This study systematically evaluates the epigenetic characteristics and clinical relevance of m1A regulators using bioinformatic methods. Our results show widespread gene expression changes for m1A regulators, which are related to the activation and inhibition of carcinogenic pathways and overall patient survival. Collectively, this investigation provides new insights into assessing tumor prognosis and targeted therapy.
N1-甲基腺苷(m1A)是一种普遍存在的 RNA 修饰,广泛影响 RNA 的结构稳定性、折叠和与蛋白质的相互作用。最近,越来越多的报道指出 m1A 调节因子在肿瘤中的作用。然而,它们的机制和临床相关性尚不清楚。本研究使用生物信息学方法系统地评估了 m1A 调节因子的表观遗传特征和临床相关性。我们的结果显示 m1A 调节因子的基因表达广泛变化,与致癌途径的激活和抑制以及患者的整体生存有关。总之,这项研究为评估肿瘤预后和靶向治疗提供了新的见解。